Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Neurones S.A. Earnings Release 2012

May 2, 2012

1548_iss_2012-05-02_c8980caf-6320-43e9-84eb-5067dec98385.pdf

Earnings Release

Open in viewer

Opens in your device viewer

PRESS INFORMATION

Heading: 1st quarter 2012 revenues

Nanterre, 3 May 2012

Organic growth up 15% in 1st quarter 2012

(in millions of euros) Q1 2012 Q1 2011 %
Revenues 78.1 66.9 + 16.7%
Of which organic growth + 15.0%

Achievements

The revenues posted over this three-month period were up 15%. This was the 7th consecutive quarter of two-figure organic growth.

This growth is similar to the 1st quarter internal growth recorded in 2011, which was up 17.4%.

At the end of March 2012, the operating profit (not audited) stood at around 8.8% (*) of revenues compared to 8.1% for the same period in 2011.

Compared to the 2011 reference document available in the Investors section on the Neurone's website (www.neurones.net), the financial situation did not experience any significant changes.

(*) after inclusion of 0.3% of expenses related to free shares and stock options

Outlook

Taking into account a volatile political and economic situation, and with constant structures, NEURONES forecasts the following for 2012:

  • over €310 million in revenues,
  • an operating profit of between 8.5% and 9.5% of revenues.

About NEURONES

With almost 3,600 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems. The size of the group has doubled over the past five years.

NYSE Euronext: Compartment B – ISIN code: FR0004050250 – NYSE symbol: NRO www.neurones.net

Press relations: Florence Gillier Communication Frédérique Guillo Tel.: +33 (0)1 41 18 85 55 [email protected]

NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 [email protected]

Investor relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 [email protected]

CONSULTING ▪ INTEGRATION ▪ OUTSOURCING

Immeuble " Le Clemenceau 1 " - 205, avenue Georges Clemenceau – F-92024 Nanterre Cedex Tel.: +33 (0)1 41 37 41 37 - Fax: +33 (0)1 47 24 40 46 – e-mail: [email protected] - www.neurones.net Société Anonyme au Capital de 9,449,103.60 € - R.C.S. NANTERRE B 331 408 336 - Code TVA FR 46331408336 - Siret 331 408 336 00021 – APE 6202A